More importantly, this study suggested that metapristone inhibited endometrial cancer cell growth via miR-492/Klf5/Nrf1 axis, which provided a new mechanism of antitumor effect of metapristone on endometrial cancer for the clinical application. The gene discussed is KLF5; the disease is endometrial cancer.